Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, Weksler B, Esteban R (2008). Thrombocytopenia associated with chronic liver disease. J. Hepatol. 48(6):1000-1007.
Crossref

Aster RH (1966). Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin. Invest. 45(5):645-657.
Crossref

Balta S, Demirkol S, Akgul EO (2013). Mean platelet volume as a surrogate marker of inflammation in patients with chronic hepatitis B. Eur. J Gastroenterol. Hepatol. 25(11):1364.
Crossref

Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, Selby PJ (1998). Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br. J. cancer 77(6):956.
Crossref

Bath PM, Butterworth RJ (1996). Platelet size: measurement, physiology and vascular disease. Blood Coagul. Fibrinolysis 7(2):157-161.
Crossref

Bruix J, Sherman M (2011). American Association for the Study of Liver D. Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020-1022.
Crossref

Carr BI (2014). Guest editorial: Platelets and cancer. Semin Oncol.41(3):300-301.
Crossref

Carr BI, Cavallini A, D'Alessandro R, Refolo MG, Lippolis C, Mazzocca A, Messa C (2014). Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro. BMC cancer 14(1):1.
Crossref

Carr BI, Guerra V (2013). Thrombocytosis and hepatocellular carcinoma. Dig. Dis. Sci. 58(6):1790-1796.
Crossref

Carr BI, Lin CY, Lu SN (2014). Platelet-related phenotypic patterns in hepatocellular carcinoma patients. Semin. Oncol. 41(3):415-421.
Crossref

Celikbilek M, Gursoy S, Deniz K, Karaman A, Zararsiz G, Yurci A (2013). Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease. Platelets 24(3):194-199.
Crossref

Ceylan B, Fincanci M, Yardimci C, Eren G, Tözalgan Ü, Müderrisoglu C, Pasaoglu E (2014). Mean platelet volume in chronic viral hepatitis. Eur. J. Gastroenterol. Hepatol. 26(2):240-241.
Crossref

Cho SY, Lee A, Lee HJ, Suh JT, Park TS (2012). Mean platelet volume in Korean patients with hepatic diseases. Platelets 23(8):648-649.
Crossref

Cho SY, Lee HJ, Park TS (2015). Mean platelet volume in patients with increased gamma-glutamyl transferase. Platelets 26(3):283-284.
Crossref

Cho SY, Yang JJ, You E, Kim BH, Shim J, Lee HJ, Lee WI, Suh JT, Park TS (2013). Mean platelet volume/platelet count ratio in hepatocellular carcinoma. Platelets 24(5):375-377.
Crossref

European Association (2012). European Association For The Study Of The L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 56(4):908-943.
Crossref

Fouad YM (2013). Chronic hepatitis C-associated thrombocytopenia: aetiology and management. Trop Gastroenterol. 34(2):58-67.
Crossref

Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD (2011). Mean platelet volume: a link between thrombosis and inflammation? Curr. Pharm. Des. 17(1):47-58.
Crossref

Griffiths L, Stratford IJ (1997). Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy. Br. J Cancer 76(6):689-693.
Crossref

Hwang SJ, Luo JC, Li CP, Chu CW, Wu JC, Lai CR, Chiang JH, Chau GY, Lui WY, Lee CC, Chang FY (2004). Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma. World J. Gastroenterol. 10(17):2472-2477.
Crossref

Jang JW, Oh BS, Kwon JH, You CR, Chung KW, Kay CS, Jung HS (2012). Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma. Cytokine 60(3):686-693.
Crossref

Karagoz E, Tanoglu A (2014). Prognostic role of mean platelet volume in patients with chronic hepatitis C. Clin. Res. Hepatol. Gastroenterol. 38(6):e113.
Crossref

Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, Theurl I, Widder W, Molnar C, Ludwiczek O, Atkins MB (2001). Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98(9):2720-2725.
Crossref

Kebapcilar AG, Taner CE, Kebapcilar L, Bozkaya G (2010). High mean platelet volume, low-grade systemic coagulation, and fibrinolytic activation are associated with pre-term delivery and low APGAR score in intrahepatic cholestasis of pregnancy. J. Matern. Fetal Neonatal Med. 23(10):1205-1210.
Crossref

Kocabay G, Karabay CY, Kalayci A, Colak Y (2014). Mean platelet volume in patients with non-alcoholic fatty liver disease: is mean platelet volume ready as a surrogate marker? Clin. Chem. Lab. Med. 52(11):e249-252.
Crossref

Kurt M, Onal IK, Sayilir AY, Beyazit Y, Oztas E, Kekilli M, Turhan N, Karaman K, Akdogan M (2011). The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepato-gastroenterology 59(117):1580-1582.

Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM, Morgan TR, Kim HY, Lee WM, Bonkovsky HL, Dienstag JL (2010). Des-γ-carboxy prothrombin and α-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology 138(2):493-502.
Crossref

Ohishi W, Cologne JB, Fujiwara S, Suzuki G, Hayashi T, Niwa Y, Akahoshi M, Ueda K, Tsuge M, Chayama K (2014). Serum interleukin‐6 associated with hepatocellular carcinoma risk: A nested case–control study. Int. J. Cancer 134(1):154-163.
Crossref

Olas B, Mielicki WP, Wachowicz B, Krajewski T (1999). Cancer procoagulant stimulates platelet adhesion. Thromb. Res. 94(3):199-203.
Crossref

Osada M, Kaneko M, Sakamoto M, Endoh M, Takigawa K, Suzuki-Inoue K, Inoue O, Satoh K, Enomoto N, Yatomi Y, Ozaki Y (2012). Causes of thrombocytopenia in chronic hepatitis C viral infection. Clin. Appl. Thrombosis/Hemostasis. 2012.
Crossref

Ozhan H, Aydin M, Yazici M, Yazgan O, Basar C, Gungor A, Onder E (2010). Mean platelet volume in patients with non-alcoholic fatty liver disease. Platelets 21(1):29-32.
Crossref

Peck-Radosavljevic M (2000). Thrombocytopenia in liver disease. Can. J. Gastroenterol. 14:60D-66D. Hematol. 50(3):173-178.

Pereira J, Accatino L, Alfaro J, Brahm J, Hidalgo P, Mezzano D (1995). Platelet autoantibodies in patients with chronic liver disease. Am. J.
Crossref

Pinedo HM, Verheul HM, D'Amato RJ, Folkman J (1998). Involvement of platelets in tumour angiogenesis? Lancet 352(9142):1775-1777.
Crossref

Purnak T, Olmez S, Torun S, Efe C, Sayilir A, Ozaslan E, Tenlik I, Kalkan IH, Beyazit Y, Yuksel O (2013). Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis. Clin. Res. Hepatol. Gastroenterol. 37(1):41-46.
Crossref

Rios R, Sangro B, Herrero I, Quiroga J, Prieto J (2005). The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis. Am. J. Gastroenterol. 100(6):1311-1316.
Crossref

Sanjo A, Satoi J, Ohnishi A, Maruno J, Fukata M, Suzuki N (2003). Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases. J. Gastroenterol. Hepatol. 18(6):638-644.
Crossref

Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, Rupaimoole R, Armaiz-Pena GN, Pecot CV, Coward J, Deavers MT (2012). Paraneoplastic thrombocytosis in ovarian cancer. N. Engl. J. Med. 366(7):610-618.
Crossref

Tahtaci M, Yurekli OT, Bolat AD, Balci S, Akin FE, Buyukasik NS, Ersoy O (2015). Increased mean platelet volume is related to histologic severity of primary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 27(12):1382-1385.
Crossref

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2012). Global cancer statistics. CA Cancer J. Clin. 65(2):87-108.
Crossref

Ukropec JA, Hollinger MK, Salva SM, Woolkalis MJ (2000). SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J. Biol. Chem. 275(8):5983-5986.
Crossref

Verheul HM, Jorna AS, Hoekman K, Broxterman HJ, Gebbink MF, Pinedo HM (2000). Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood 96(13):4216-4221.

Voutsadakis IA (2014). Thrombocytosis as a prognostic marker in gastrointestinal cancers. World J. Gastrointest. Oncol. 6(2):34-40.
Crossref

Wang CS, Yao WJ, Wang ST, Chang TT, Chou P (2004). Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection. Clin. Infect Dis. 39(6):790-796.
Crossref

Wartiovaara U, Salven P, Mikkola H, Lassila R, Kaukonen J, Joukov V, Orpana A, Ristimaki A, Heikinheimo M, Joensuu H, Alitalo K (1998). Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb. Haemost. 80(1):171-175.

Wong VW, Yu J, Cheng AS, Wong GL, Chan HY, Chu ES, Ng EK, Chan FK, Sung JJ, Chan HL (2009). High serum interleukin‐6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int. J. cancer 124(12):2766-2770.
Crossref